Two Bear Capital

Montara Therapeutics is a biotechnology company specializing in brain-specific pharmacology. It leverages human genetics and machine learning to identify and validate drug targets, aiming to enhance the safety and efficacy of treatments for neurological diseases.

QuSecure is a post-quantum cybersecurity company based in Menlo Park, California, delivering enterprise security solutions designed to address current and future quantum threats. It offers the QuProtect software platform, a holistic end-to-end quantum-security-as-a-service framework that provides zero-trust, quantum-resilient technology and crypto agility to protect networks, cloud environments, edge devices, end users, and satellite communications. The company also provides automated cryptographic testing and consulting services covering governance, compliance, and security strategy, along with technologies such as a security management server, quantum-resilient blockchain and wallet, and biometric identity features for blockchain applications. QuSecure aims to safeguard organizations from cyber attacks and emerging quantum risks with minimal disruption to existing systems.

Selector AI is a technology company that offers an operational intelligence platform designed for managing multi-domain network and application infrastructures across diverse cloud environments. The platform ingests data from various sources, employs automated anomaly detection using AI/ML algorithms, and delivers actionable insights to help clients meet their service key performance indicators (KPIs). It facilitates seamless collaboration among operators via messaging platforms, offers search-driven querying with a conversational user experience, and automates data engineering pipelines.

Talus Bio is a biotechnology company specializing in drug discovery. It focuses on developing therapies targeting challenging cancer transcription factors using its proprietary MARMOT platform, which integrates functional proteomics, automated biology, machine learning, AI, synthetic chemistry, and computational biology to design and analyze drugs, proteins, and genomics.

Montara Therapeutics is a biotechnology company specializing in brain-specific pharmacology. It leverages human genetics and machine learning to identify and validate drug targets, aiming to enhance the safety and efficacy of treatments for neurological diseases.

Elisity specializes in securing enterprise assets and data by offering a unified policy and identity-based access solution powered by AI. Its platform continuously verifies user credentials, location, permissions, and device behavior to enforce granular access control policies, enabling zero-trust security.

Binarly is a global firmware and software supply chain security company founded in 2021 and based in Los Angeles. Its flagship Binarly Transparency Platform is an enterprise-class, AI-powered solution used by device manufacturers, original equipment manufacturers and product security teams to identify known and unknown vulnerabilities, misconfigurations and signs of malicious code implantation. The platform performs in-depth firmware introspection using proprietary machine learning and code analysis techniques to detect threats that originate below the operating system. Validated remediation playbooks help reduce the cost and time to respond to security exposures, supporting protection for businesses, critical infrastructure and consumers worldwide.

Dymium is addressing one of the most pressing issues organizations are faced with today: how to securely and cost-effectively manage the data access requirements across a proliferation of data in the midst of an advancing world of cloud technology, data analytics, distributed development environments and AI-projects. Dymium takes data protection to where your data lives rather than you having to move it, make copies of it or build yet another data lake or warehouse. The Dymium Platform uniquely combines a zero-trust architecture, real-time data transformation services and universal access policies across your existing data infrastructure wherever that data may live so that it is more secure, efficient and cost-effective to innovate. We believe that you don’t need to move your data or make more copies of your data in order for you to use it for innovation. This only opens up your organization to greater risk and unnecessary cost.

TileDB, Inc. is a technology company specializing in the management of multi-dimensional array data, primarily for scientific applications. Founded in 2017 and headquartered in Cambridge, Massachusetts, with an additional location in Athens, Greece, TileDB offers a cloud-based storage platform and embedded storage engine. Its innovative software is designed to handle diverse data types, including unstructured and multimodal data, making it suitable for complex scientific inquiries such as genomic research and biomedical imaging. TileDB enables users to access, analyze, and share intricate datasets effectively, supporting scientific teams in pharmaceutical and biotechnology sectors to advance drug discovery and other research initiatives. Through its robust platform, TileDB facilitates parallel data analytics and integrates various dimensions and attributes within data arrays, positioning itself as a critical tool for scientific breakthroughs.

Graphiant is a Silicon Valley-based networking company focused on software-defined wide area networking. Founded in 2020, it develops SD-WAN technology and offers Graphiant Network Edge, a software-as-a-service platform that connects the enterprise WAN, hybrid cloud, network edge, customers, and partners, enabling rapid, enterprise-grade connectivity. Based in California, Graphiant aims to simplify and accelerate connectivity for large organizations by delivering agility and scalable network performance across on-premises, cloud, and edge environments.

Abilita Bio is a biotechnology company that focuses on enabling the discovery and development of drugs targeting membrane proteins, including G Protein Coupled Receptors (GPCRs) and ion channels.

Novoron Bioscience develops therapeutic approaches aimed at repairing damage and treating diseases of the central nervous system. The company concentrates on lipoprotein receptor biology to create CNS therapies, with preclinical programs addressing Alzheimer's disease and other tauopathies, multiple sclerosis, spinal cord injury, and related demyelinating conditions. Its platform explores both whole-receptor and micro-domain LDL receptor pathways to enable neuroprotection and recovery from CNS injury. Based in San Diego, Novoron Bioscience pursues novel biologics and agents intended to advance treatment options where current therapies are limited.

Founded in 2015, Arch Systems designs a modular hardware platform for industrial IoT applications. Its device-to-cloud solution enables manufacturers to create custom connected devices and improve machine utilization by up to 40%. The company focuses on electronics and discrete manufacturing supply chains.

CIQ specializes in enterprise-grade support for industry-standard software solutions, focusing on software infrastructure solutions, security tools, and workflow automation.

Selector AI is a technology company that offers an operational intelligence platform designed for managing multi-domain network and application infrastructures across diverse cloud environments. The platform ingests data from various sources, employs automated anomaly detection using AI/ML algorithms, and delivers actionable insights to help clients meet their service key performance indicators (KPIs). It facilitates seamless collaboration among operators via messaging platforms, offers search-driven querying with a conversational user experience, and automates data engineering pipelines.

Novoron Bioscience develops therapeutic approaches aimed at repairing damage and treating diseases of the central nervous system. The company concentrates on lipoprotein receptor biology to create CNS therapies, with preclinical programs addressing Alzheimer's disease and other tauopathies, multiple sclerosis, spinal cord injury, and related demyelinating conditions. Its platform explores both whole-receptor and micro-domain LDL receptor pathways to enable neuroprotection and recovery from CNS injury. Based in San Diego, Novoron Bioscience pursues novel biologics and agents intended to advance treatment options where current therapies are limited.

Novoron Bioscience develops therapeutic approaches aimed at repairing damage and treating diseases of the central nervous system. The company concentrates on lipoprotein receptor biology to create CNS therapies, with preclinical programs addressing Alzheimer's disease and other tauopathies, multiple sclerosis, spinal cord injury, and related demyelinating conditions. Its platform explores both whole-receptor and micro-domain LDL receptor pathways to enable neuroprotection and recovery from CNS injury. Based in San Diego, Novoron Bioscience pursues novel biologics and agents intended to advance treatment options where current therapies are limited.

Elisity specializes in securing enterprise assets and data by offering a unified policy and identity-based access solution powered by AI. Its platform continuously verifies user credentials, location, permissions, and device behavior to enforce granular access control policies, enabling zero-trust security.

PulseData AI, established in 2015 and headquartered in New York, specializes in healthcare technology. It develops machine learning software that helps healthcare providers identify patients at high risk of adverse, preventable medical outcomes. The company's platform analyzes vast amounts of patient data to predict health trends, enabling care management teams to deliver timely, targeted care, and ultimately reduce preventable illnesses and medical costs.

Graphiant is a Silicon Valley-based networking company focused on software-defined wide area networking. Founded in 2020, it develops SD-WAN technology and offers Graphiant Network Edge, a software-as-a-service platform that connects the enterprise WAN, hybrid cloud, network edge, customers, and partners, enabling rapid, enterprise-grade connectivity. Based in California, Graphiant aims to simplify and accelerate connectivity for large organizations by delivering agility and scalable network performance across on-premises, cloud, and edge environments.

TileDB, Inc. is a technology company specializing in the management of multi-dimensional array data, primarily for scientific applications. Founded in 2017 and headquartered in Cambridge, Massachusetts, with an additional location in Athens, Greece, TileDB offers a cloud-based storage platform and embedded storage engine. Its innovative software is designed to handle diverse data types, including unstructured and multimodal data, making it suitable for complex scientific inquiries such as genomic research and biomedical imaging. TileDB enables users to access, analyze, and share intricate datasets effectively, supporting scientific teams in pharmaceutical and biotechnology sectors to advance drug discovery and other research initiatives. Through its robust platform, TileDB facilitates parallel data analytics and integrates various dimensions and attributes within data arrays, positioning itself as a critical tool for scientific breakthroughs.

Founded in 2016, Inimmune is a biotechnology company based in Missoula, Montana. It specializes in the discovery and development of novel immunotherapeutics to treat or prevent conditions such as oncology, allergic rhinitis, food allergy, infectious diseases, and bacterial infections.

VERAFĪ operates as a SaaS-based platform focused on private intelligence and due diligence, aiming to enhance fraud prevention in various sectors. The company integrates human expertise from the intelligence community with advanced machine learning technology, catering to professionals in private equity, venture capital, and commercial credit. This approach allows users to access critical intelligence efficiently, facilitating a smoother deal flow process. By addressing the needs of the corporate and human diligence markets, VERAFĪ provides tools for effective KYC (Know Your Customer), enhanced due diligence, pre-employment screening, and fraud detection, thus promoting a more secure business environment.

VERAFĪ operates as a SaaS-based platform focused on private intelligence and due diligence, aiming to enhance fraud prevention in various sectors. The company integrates human expertise from the intelligence community with advanced machine learning technology, catering to professionals in private equity, venture capital, and commercial credit. This approach allows users to access critical intelligence efficiently, facilitating a smoother deal flow process. By addressing the needs of the corporate and human diligence markets, VERAFĪ provides tools for effective KYC (Know Your Customer), enhanced due diligence, pre-employment screening, and fraud detection, thus promoting a more secure business environment.

Graphiant is a Silicon Valley-based networking company focused on software-defined wide area networking. Founded in 2020, it develops SD-WAN technology and offers Graphiant Network Edge, a software-as-a-service platform that connects the enterprise WAN, hybrid cloud, network edge, customers, and partners, enabling rapid, enterprise-grade connectivity. Based in California, Graphiant aims to simplify and accelerate connectivity for large organizations by delivering agility and scalable network performance across on-premises, cloud, and edge environments.